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DYSBIOSIS AND CLASSIC DISEASES
• Infection and chronic intestinal inflammation.
• Autoimmune diseases: Inflammatory bowel disease, allergen-induced
airway hyperreactivity, DM-I.
• Metabolic syndrome (obesity and DM-II) and cardiovascular diseases
(arteriosclerosis)
CONCLUSIONS
• A new organ has just been discovered.
• Microorganisms modulate our immune system
to promote self-tolerance and gut homeostasis.
NEW TREATMENT APPROACHES
Direct modification of microbiota
• Antibiotics: to treat disorders associated with a known pathobiont.
• Faecal transplant: Very effective for Clostridium difficile infections.
It may be efficiency variations between individuals, risk of developing
new diseases and the need of long-term repetitions.
Indirect modification of microbiota
• Probiotics: Bifidocabteria, Lactobacilli, Streptococci
• Prebiotics: Fructo-oligosaccharides and inulin.
They may help to reduce or prevent gastrointestinal signs.
INTESTINAL MICROBIOME AND THE IMMUNE SYSTEM
CROSSTALK. The communication between microbiota and the host to
adjust the antimicrobial program.
• Objectives: tolerance to the own microbiota and immune response
against the foreign.
• Mechanisms: transcriptional reprogramming and epigenetic
programming of host cells.
• Process and compounds: Recognition of bacterial patterns (PRRs) by
specific epithelial receptors (PAMPs) to adjust the antimicrobial
program (mucus, antimicrobial peptides, IgA, cytokines...). The own
microbiota drives to a negative feedback. Bacterial metabolites, such
SCFA, AA or Indole, also contribute to the crosstalk.
Epithelial NLRC4 expulse infected or carcinogenic enterocytes.
INNATE IMMUNE SYSTEM:
FUNCTIONS OF THE INTESTINAL MICROBIOTA
• Microbial antagonism
• Optimization of nutrient absorption
• Immune System development
THE MICROBIOTA 
• Complex community of microorganisms found normally on the skin and mucous surfaces of all multicellular organisms in a symbiotic relationship.
• The role of the microbiota in homeostasis and in classic diseases has been re-discovered, enhancing the design of new therapeutic approaches.
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ADDAPTATIVE IMMUNE SYSTEM
• Mucosal IgA: Produced by B cells, in the lamina propria (Peyer Patch).
They prevent the microbial direct interaction with the host and
regulate the composition of the microbiota, to keep it diversified.
• TH17 cells: Prevent from extracellular infection (bacterial and fungi)
and favor IgA synthesis. Some external factors favor its change to
pathogenic cells, which can promote auto-antibodies production and
autoimmune diseases in predisposed individuals.
• Treg cells: Cut down Teff, TH17 and myeloid cell population, to promote
intestinal tolerance. Bifidobacterium, Lactobacilli, Clostridium and
Bacteroides fragilis enhance the Treg cells population.
• Cancer: bacterial substances
that cause DNA damage
directly or sustaining an
inflammatory environment,
and bacteria into neoplasia
increase its growth.
• Neurodegenerative disease:
Parkinson: α-syn pathology
might be triggered in the
gut by bacterial endotoxins
and reach the brain via ENS
(vagus nerve).
• Correlations have been found between dysbiotic patterns and classic diseases.
• New therapeutic and diagnostic forms focused on the gut microbiota may be developed
in the future.
• Myeloid cells:
Its production, maturation
and biology depend on the
complexity of bacterial
antigens.
Low microbial complexity is
related to a major disease
incidence.
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